跳至主要内容
临床试验/CTRI/2022/12/048606
CTRI/2022/12/048606尚未招募3 期

Efficacy and safety of nebulized 7% hypertonic saline in the treatment of acute bronchiolitis :A randomised control trial

ONE0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
ONE

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Children aged 1-24 months of age
  • 2. Diagnosed with bronchiolitis- defined as viral prodrome for 2-3 days followed by LRTI as tachypnea, bilateral wheeze/ crepitations with or without crepitations
  • 3. Bronchiolitis severity score more than or equal to 4

排除标准

  • 1. A previous history of wheezing/ diagnosis of asthma
  • 2.Any use of bronchodilators within 2 hours of presentation
  • 3.History of congenital heart disease/ chronic pulmonary disease

研究者

发起方
ONE

相似试验

Effect of 7% hypertonic saline in bronchiolitis | 临床试验